Hyeglo Beauty Raises Rs 7 Crore Led by Sauce in Seed Round

Delhi-based beauty startup Hyeglo Beauty has raised Rs 7 crore — roughly $830,000 at current exchange rates — in a funding round led by Sauce, according to Indian Startup Times. The round, closed this year, also drew participation from Giga Capital, Consumer Collective, Reckitt's Arjun Purkayastha and The Patient Capital.

The figure is modest by D2C beauty standards, where seed rounds frequently cross $2 million. But the investor list carries weight: Reckitt is a global consumer goods giant, and Arjun Purkayastha's involvement connects a months-old brand to an established consumer health and hygiene operator's expertise.

What will the money fund?

Hyeglo plans to deploy the fresh capital across four areas: research and development, new product launches, brand building and team expansion. The company restated those priorities in its announcement, adding that it intends to strengthen product development capabilities and expand its portfolio.

No timeline accompanied the spending plan. The company did not disclose a valuation, revenue figures or how long the capital is expected to last. In plain words: the money is committed, but the milestones are not.

Who is behind Hyeglo?

Founder Kanupriya Ahluwalia launched Hyeglo this year, making it one of the youngest companies in India's crowded D2C beauty market. The brand operates in the direct-to-consumer model, selling straight to shoppers rather than through retail intermediaries.

Hyeglo's positioning sits at the intersection of two categories that Indian consumers usually buy separately: skincare and makeup. The company describes its products as combining clinically tested ingredients, skincare actives and pigments — the logic being that everyday makeup can carry genuine skin benefits rather than sitting inert on the surface.

The company follows what it calls a skin science-led approach to product development. Dermatological expertise and professional consultations play a role in shaping its formulations, according to the company's own description of its process.

That claim rests partly on its advisory bench. Hyeglo works with experts including Dr Sonal Tibrewal Garg, an MD in Dermatology. The company did not disclose how many products the dermatologist has reviewed, nor whether the partnership is a formal advisory role.

Why does skin-makeup hybrid play matter?

The "skincare-infused makeup" segment is the brand's declared differentiator, and it arrives amid sustained demand for skin-first formulations among Indian consumers. Hyeglo's bet is that shoppers will pay for makeup that behaves like a treatment product.

The proof is not yet on the table. The company has not disclosed sales figures, unit economics or customer acquisition costs — the metrics that separate a positioned brand from a performing one. Whether dermatologist involvement translates into measurable clinical claims, and whether consumers can tell the difference at checkout, remains the open question.

What comes next?

With Rs 7 crore in the bank and a fresh investor syndicate, Hyeglo's stated roadmap is straightforward: more products, more people, more brand. The competitive test will be whether a first-year startup can out-develop the incumbent D2C beauty players who already hold distribution, data and marketing budgets several multiples larger than this entire raise.